SWOG S1501_Temporarily Closed

Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III

For more information about this clinical trial

Schema & Eligibility SWOG S1501

Available at:

CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Delbert Day Cancer Institute at PCRMC, Rolla, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL
Mercy Hospital, St. Louis, MO
St Louis Cancer & Breast Institute, Ballwin, MO
St Louis Cancer & Breast Institute, St. Louis, MO
Mercy Hospital, Joplin, MO
Mercy Clinic Cancer & Hematology, Rolla, MO
Mercy Hospital, Oklahoma City, OK
Mosaic Life Care, St. Joseph, MO

Ask your physician about participating in this clinical trial or call us.